Motif Bio plc is Classified as an AIM Rule 15 Cash Shell
Hit enter to search or ESC to close
About
Legacy Program
Iclaprim
Investors
AIM Investors
AIM Announcements
Financial Reports
Annual Reports
Interim Financial Reports
SEC Filings
Corporate Governance
Board of Directors
Governance Documents
Contact the Board
Contact
Announcements
Motif’s Dr. David Huang on Nature’s “Combating Antibiotic Resistance” Webcast
By
Motif
March 9, 2016
March 14th, 2016
No Comments
Share
Tweet
Share
Pin
Motif Bio plc is Classified as an AIM Rule 15 Cash Shell
About
Legacy Program
Iclaprim
Investors
AIM Investors
AIM Announcements
Financial Reports
Annual Reports
Interim Financial Reports
SEC Filings
Corporate Governance
Board of Directors
Governance Documents
Contact the Board
Contact
This website uses cookies to improve your experience. You can opt-out if you wish.
Accept
Read More
Privacy & Cookies Policy
Close
Non Necessary
non-necessary
This is an non-necessary category.
Analytics
analytics
